A molecular diagnostics company wants to expand its new cartridge-based platform to help orthopedic surgeons make more informed care decisions for patients with a potential joint […]

“Screening for colorectal cancer can be life-saving, but Americans still lag behind Federal government screening goals because current screening options can be inconvenient and uncomfortable for […]

Year 2020 has been set as the delivery date for 500,000 whole exome sequences from the UK Biobank cohorts. A consortium of six drug companies will […]

– Inked new collaboration and commercialization deals with MGI to leverage Curetis´ sample preparation technology – Enabling short-term commercialization of NGS-based molecular microbiology Amsterdam, the Netherlands, […]

Originally published January 7, 2018 at 5:43 pm Dr. Robert Day, former director of the Fred Hutchinson Cancer Center who brought the campus to South Lake […]

TORONTO, ON–(Marketwired – November 29, 2017) – In an upcoming webinar hosted by Xtalks on Thursday, December 14, 2017, leading diagnostics specialty CRO Health Decisions will introduce […]

21. NOVEMBER 2017.   Berlin (Germany) and Germantown, MD (U.S.A.), November 21, 2017 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY) announced the Centers of Medicare […]

Epigenomics Initiates €5.5M Private Placement Sep 21, 2017, NEW YORK (GenomeWeb) – Epigenomics said today that it plans to raise approximately €5.5 million ($6.5 million) in a […]

BioreclamationIVT has acquired Asterand Bioscience™, a global provider of human tissue and research solutions with a focus on the oncology market. Asterand Bioscience advances drug research […]